Professor of Health Economics & Director, HERC
- Professor of Health Economics, University of Oxford
- Academic, Melbourne School of Population and Global Health
- Honorary, Melbourne Institute of Applied Economic and Social Research
Professor Philip Clarke re-joined HERC in August 2018 after previous appointments at the Universities of Sydney and Melbourne in Australia. He is a Fellow of the Academy of the Social Sciences in Australia (ASSA).
His research interests include developing methods to value the benefits of improving access to health care, health inequalities and the use of simulation models in health economic evaluation. Philip has been involved in the development of the UKPDS Outcomes Model, a health economic simulation model for type 2 diabetes.
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.
Chan JCN. et al, (2021), Lancet, 396, 2019 - 2082
Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities.
Duch R. et al, (2021), Proc Natl Acad Sci U S A, 118
Weight loss interventions on health-related quality of life in those with moderate to severe obesity: Findings from an individual patient data meta-analysis of randomized trials.
Buckell J. et al, (2021), Obes Rev
Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS NN ).
Leal J. et al, (2021), Diabet Med
Public opinion on global rollout of COVID-19 vaccines.
Clarke PM. et al, (2021), Nat Med